233183 Sigma-AldrichClodronate, Disodium Salt - CAS 88416-50-6 - Calbiochem
A non-amino, chloro-containing bisphosphonate that acts as a potent inhibitor of osteoclast-mediated bone resorption.
More>> A non-amino, chloro-containing bisphosphonate that acts as a potent inhibitor of osteoclast-mediated bone resorption. Less<<Clodronate, Disodium Salt - CAS 88416-50-6 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: Clodronate, Disodium, Tetrahydrate, Dichloromethylene-bisphosphonate, Disodium Tetrahydrate
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 88416-50-6 | CH₂Cl₂O₆P₂Na₂ • 4H₂O |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 233183-10MGCN | 塑胶安瓿;塑胶针药瓶 | 10 mg |
| Product Information | |
|---|---|
| CAS number | 88416-50-6 |
| ATP Competitive | N |
| Form | White solid |
| Hill Formula | CH₂Cl₂O₆P₂Na₂ • 4H₂O |
| Chemical formula | CH₂Cl₂O₆P₂Na₂ • 4H₂O |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Structure formula Image | |
| Quality Segment | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | SZ7640700 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| 产品目录编号 | GTIN |
| 233183-10MGCN | 04055977217773 |
Documentation
Clodronate, Disodium Salt - CAS 88416-50-6 - Calbiochem MSDS
| 职位 |
|---|
Clodronate, Disodium Salt - CAS 88416-50-6 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 233183 |
参考
| 参考信息概述 |
|---|
| Lehenkari, P.P., et al. 2002. Mol. Pharmacol. 61, 1255. Virtanen, S.S., et al. 2002. Cancer Res. 62, 2708. Smith, R., et al. 1971. Lancet 1, 945. Fleisch, H., et al. 1969. Nature 223, 211. |



